期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 16, 期 11, 页码 1097-1099出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14737140.2016.1241150
关键词
Mesothelioma; beta-blockers; naftopidil; CD26; dipeptidyl peptidase IV; anti-CD26 monoclonal antibody; amatuximab; nintedanib